The antibacterial activity and modes of LI-F type antimicrobial peptides against Bacillus cereus in vitro

J Appl Microbiol. 2017 Sep;123(3):602-614. doi: 10.1111/jam.13526.

Abstract

Aims: LI-Fs are a family of highly potent cyclic lipodepsipeptide antibiotics with a broad antimicrobial spectrum (Gram-positive bacteria and fungi). In this study, LI-F-type antimicrobial peptides (AMP-jsa9) composing of LI-F03a, LI-F03b, LI-F04a, LI-F04b and LI-F05b were isolated from Paenibacillus polymyxa JSA-9. To better understand the antimicrobial mechanism of AMP-jsa9, the potency and action(s) of AMP-jsa9 against Bacillus cereus were examined.

Methods and results: Flow cytometry, confocal laser microscopy, scanning electron microscopy, transmission electron microscopy (TEM) and atomic force microscopy observation, as well as determination of peptidoglycan and cell wall-associated protein and other methods were used. The results indicate that AMP-jsa9 exhibits strong, broad-spectrum antimicrobial activity. Moreover, AMP-jsa9 targets the cell wall and membrane of B. cereus to impair membrane integrity, increase membrane permeability and enhance cytoplasm leakage (e.g. K+ , protein, nucleic acid). This leads to bacterial cells with irregular, withered and coarse surfaces. In addition, AMP-jsa9 is also able to bind to DNA and break down B. cereus biofilms.

Conclusions: In this study, the action mechanism of LI-Fs against B. cereus was clarified in details.

Significance and impact of the study: The results of this study provide a theoretical basis for utilizing AMP-jsa9 or similar analogues as natural and effective preservatives in the food and feed industries. These efforts could also stimulate research activities interested in understanding the specific effects of other antimicrobial agents.

Keywords: Bacillus cereus; AMP-jsa9; LI-F-type antimicrobial peptides; Paenibacillus polymyxa JSA-9; action mechanism.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacillus cereus / drug effects*
  • Bacillus cereus / genetics
  • Bacillus cereus / metabolism
  • Bacterial Proteins / pharmacology*
  • Depsipeptides / pharmacology*
  • Enkephalin, Methionine / analogs & derivatives*
  • Enkephalin, Methionine / pharmacology
  • Paenibacillus polymyxa / chemistry
  • Protein Precursors / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Depsipeptides
  • LI-F04a peptide, Bacillus
  • Protein Precursors
  • fusaricidin C
  • fusaricidin D
  • Enkephalin, Methionine
  • peptide F